FDA Classifies Preeclampsia Prognostic Test as Class II Device with Special Controls

Summary

The FDA has classified the prognostic test for development or progression of preeclampsia into Class II, a designation that requires special controls to ensure the device's safety and effectiveness, with the goal of increasing patients' access to innovative devices while reducing regulatory burdens.